Angela Blake-Haskins

Angela Blake-Haskins is the Executive Director of Formulation Development and Drug Product Manufacturing at Cullinan Therapeutics since April 2024. Prior to this role, Angela served as Senior Director at Gilead Sciences from August 2016 to March 2024, overseeing Biologics Formulation and Drug Product Process Development. Angela's earlier experience includes positions as Director at Gilead Sciences, Senior Research Scientist II at MedImmune, Senior Scientist at GlaxoSmithKline, and various roles at Human Genome Sciences focusing on protein formulation development. Angela holds a Ph.D. in Chemical Engineering from Carnegie Mellon University and both a B.S. and M.S. in Chemical Engineering from Rensselaer Polytechnic Institute.